The health effects of radiation have been a focus for research since early in the 20th century. As the century ends, extensive experimental and epidemiologic evidence has been accumulated that addresses the adverse consequences of radiation exposure; epidemiologic studies of radiation-exposed groups from the general population and specific occupational groups provide quantitative estimates of the cancer risks associated with exposure. This report provides a perspective on the extensive epidemiologic evidence on the health effects of ionizing radiation and on likely needs for further epidemiologic research on radiation and health. Epidemiologic studies have proved informative on the quantitative risks of radiation-caused cancer but we now face the challenges of more precisely characterizing risks at lower levels of exposure and also of assessing modifiers of the risks, including dose rate, genetic susceptibility, and other environmental exposures. This report considers investigative approaches, such as pooled analysis of multiple data sets, that can be used to address these complex questions and the limitations of these approaches for addressing societal concerns about the risks of radiation exposure.
Introduction
One hundred years have now elapsed since Roentgen's 1895 discovery ofX-rays. In the ensuing years, radiation has become widely used for medical, industrial, and other purposes. The world's population has been exposed to radiation through its medical uses and by radiation-emitting products, employment in industries using radiation, accidents, and nuclear weapons. Moreover, it has been learned that most of the dose received by the general population comes from natural and not man-made sources (1, 2) . These natural sources include cosmic rays, terrestrial radiation, and internally deposited radionuclides (Table 1) . Radon, the sixth decay product of uranium-238, is the largest contributor to population dose. Radon is ubiquitous in indoor environments, which it enters from the soil; its short-lived progeny includes two alphaemitters, polonium-218 and polonium-214, which internally irradiate the lung when inhaled. Estimates of total radiation exposure for the United States (Table 1) show that radon contributes over half of the estimated effective dose, and manmade sources contribute less than 20% (1) . Although sufficient data are not available for making similar estimates on a worldwide basis, the conclusions in the 1988 and 1993 reports of the United Nations Scientific Committees on the Effects of Atomic Radiation (UNSCEAR) (2, 3) on the worldwide balance between exposure from natural and man-made sources were similar to that for the United States.
The health effects of radiation have been a focus for research since early in the 20th century. Radiation burns and radiation sickness were quickly recognized as early operators of X-ray machines suffered the consequences of high levels of exposure (4) . The problem of radiationcaused skin cancers was also soon noted. By mid-century, the potential for external irradiation and internally deposited radionuclides to cause cancer at other sites was documented through the unfortunate experiences of the underground miners in Schneeberg and Joachimsthal in Central Europe, the radium dial painters in the United States, and the survivors of the Hiroshima and Nagasaki atomic bomb blasts in Japan.
Voluminous experimental and epidemiologic evidence is now available on the health effects of radiation. Throughout the world, government and nongovernment agencies have used the epidemiologic data to estimate the risks of radiation as a basis for setting limits for exposure; the complementing experimental data have been used to develop biologically appropriate risk models and to support assumptions made in analyzing and applying the epidemiologic findings. In Nevertheless, the health effects of radiation remain a topic of widespread societal concern in spite of the deepening scientific knowledge. Risks of medical radiation, nuclear facilities, and occupational exposures have been questioned repeatedly as to their acceptability; on the other hand, these radiation exposures arise from essential societal applications of technology and there is concern that the public could be made too phobic of radiation by exaggerated risk estimates. Consequently, there has been sustained questioning of the epidemiologically based risk models. For example, the recent recognition of the magnitude of radon's contribution to This report provides a perspective on likely needs for further population-based research on radiation and health; this research will take place on a background of advancing understanding of the mechanisms by which radiation causes cancer and of the genetic determinants of susceptibility. The article also forecasts areas in which epidemiologic investigation will be needed and the challenges that will be faced in these investigations. Selected examples are used to illustrate these predictions. The article does not attempt to comprehensively review the current status of the full range of evidence on radiation and disease; a number of comprehensive reviews on this topic are available (6) (7) (8) Quantitative estimates of the risks have been derived primarily from epidemiologic studies of radiation-exposed populations. For low linear energy transfer (low-LET) radiation, the study of the atomic bomb survivors of Hiroshima and Nagasaki has been a principal data source. This is a prospective cohort study involving follow up of approximately 93,000 survivors of the atomic bombings and 27,000 additional persons who lived in the two cities in 1950 but were not present at the time of the blasts. The population was not enrolled until 5 years had passed since the bombings, so survival for at least 5 years was mandatory for enrollment in the cohort. For each person, radiation exposure was estimated based on location at the time of the blast, shielding, and other factors. Unique features of the population include its size, the virtually instantaneous delivery of exposure at the time of the blast, and the lengthy follow up. Initially, the participants were followed for cancer mortality (9), but incidence has now been added (10, 11) .
Excess occurrence of cancer is assessed by comparing the number of cancers among cohort members exposed to radiation with projections of expected numbers of cases based on the experience of the participants who were not exposed. Quantitative estimates of risk are made by applying regression models that calculate the relationship of the excess risk beyond background with exposure to radiation (or with estimated organ dose). This approach was followed by the BEIR V Committee (7) and in subsequently reported analyses of mortality for 1950 to 1987 (8) and for cancer incidence for 1958 to 1987 (10, 11) . In the relativerisk models used in these analyses, the risk coefficients describe the relative increment in risk beyond background per unit of exposure. Positive coefficients are evident for most sites of solid tumors; leukemias, except for chronic lymphocytic leukemia, were also in excess. Tracking cancer incidence adds information on sites for which cancers are infrequently fatal-thyroid, skin, salivary gland, and new leukemias and lymphomas. The excess risk coefficients derived from this study remain a principal basis for estimating risks of radiation-associated cancer.
We have also gained substantial methodologic insights from the studies of atomic bomb survivors. The data set has been a challenge to analysts and an impetus for the development and application of new models for longitudinal analysis (9) . The lengthy follow up of the cohort provided opportunity to characterize the time dependence of risk and to determine if the excess should be considered additive or multiplicative to the background risk. The general tendency for the data to be better fit by multiplicative models has led to the now universal application of relative risk models (12) and the extension of those models to include time-dependent effects. Throughout the study there have been concerns about error in the exposure estimates and misclassification of cancer diagnoses; in fact, dose estimates were revised in 1986 and questions have been subsequently raised as to the assumptions underlying these most recent revisions (9) . These concerns have sparked the application of statistical methods for considering the consequences of errors in diagnoses (13) and exposure and dose (14) .
For low-LET radiation, data from numerous additional epidemiologic studies now also supply site-specific estimates of cancer risk. The participants in these studies have been exposed either through therapeutic radiation or through their jobs. For cancer of the breast, for example, the 1994 UNSCEAR report lists 10 populations in addition to the atomic bomb survivors (Table 2 ). These studies generally indicate excess incidence of breast cancer, although there is a wide range of risk coefficients and substantial imprecision in some of the risk estimates. However, these studies differ substantially in the quality of the dose estimates and population characteristics that may modify the risk of radiation. For most other cancer sites, risk estimates are also available from a number of studies (7, 8 (26, 27) . On the other hand, the 1994 UNSCEAR report (8) Pooling of data from higher-dose studies of radiation-exposed workers and therapeutically exposed persons has proved informative because of the statistical power gained beyond that of the individual studies. The pooled analyses of data from underground miners are illustrative. The BEIR IV Alpha Committee (6) analyzed data from four studies (Colorado Plateau, Beaverlodge, and Ontario uranium miners and Malmberget iron miners) that included a total of 360 lung cancer deaths. Poisson regression analysis was used to fit a series of relative risk models to the individual data sets and to the combined data. The individual data sets were found to be consistent and the committee reported a preferred model based on the pooled data. The model was multiplicative but the effect of exposure varied with interval since exposure and with attained age. The model represented a significant departure from prior analyses, which had emphasized either simple attributable risk or relative risk models. The recent pooled analysis extended this approach to the 11 cohorts extant in the early 1990s that had individual exposure estimates and a significant number of lung cancer cases (20) . The total population comprised about 68,000 men who had experienced 2700 lung cancer deaths during follow up. This larger sample size facilitated a more precise characterization of the risk of radon and added a term to the model for an effect of dose rate. Other illustrative analyses have been reported for nuclear workers (15) and for thyroid cancer following exposure to external radiation (17) .
Such pooled analyses would appear to represent the optimum approach for future assessments of the cancer risks associated with lower levels of radiation. The anticipated pooling of the case-control studies of indoor radon and lung cancer has been facilitated by a series of workshops of the investigators and a similar high level of cooperation has been achieved for other pooled analyses.
Dose-Rate Effects
Typical radiation exposures of the general population are sustained at lower dose rates than those received by participants in the epidemiologic studies. At the extreme, the radiation from the atomic bomb blasts in Hiroshima and Nagasaki was received instantaneously. The radon-exposed underground miners received exposures across a range of a few months to their full working lifetimes, while radon exposure indoors is continuous. Consequently, to project radiation risks for the general population, an assumption is needed as to the effect of differing dose rates for the observed populations and the general population.
For low-LET radiation, risk estimates derived at high doses and high dose rates are reduced by the dose-rate reduction factor (7, 8) . While some studies provide information on consequences of dose rate, the dose-rate reduction factors have been empirically derived and their biologic and epidemiologic basis remains uncertain (31). It is not realistic to anticipate that epidemiologic evidence will characterize dose-rate reduction factors at the doses of greatest concern for typical population exposures.
For high-LET radiation, there is both experimental and epidemiologic evidence that lower dose-rate exposures have increased risk (inverse dose-rate effect) (12, 20) . The recent pooled analysis of data from underground miners showed that the excess relative risk of lung cancer increased as the exposure rate decreased. However, the lowest dose-rate category in this analysis is about two orders of magnitude above the typical exposure rates for the general population. Thus to estimate the risk posed by residential radon, assumptions are needed not only on the shape of the dose-response relationship but also on the magnitude of the dose-rate effect at typical environmental exposures. A simple extrapolation of the estimated dose-rate effect from the miner data would lead to unrealistically high risk estimates. Brenner (32) has proposed a biophysical model that postulates a dependence of the dose-rate effect on dose; this model leads to the conclusion that a dose-rate effect should not be present at low doses. A recent analysis of data from the 11 cohorts of underground miners is consistent with this postulated dependence of the inverse dose-rate effect on dose (19 (34) . The cluster, first reported in a television program, was quickly followed by confirmation of increased leukemia mortality rates for one of the adjoining districts (34) . This single cluster has prompted a remarkable series of descriptive and analytic investigations and remains unexplained. The single explanation linking the cluster to the nudear facility-paternal exposure to radiation-has not been sustained by studies elsewhere (35 providing evidence to the public of the consequences of exposure; providing assurance to the public that the projected doses were, in fact, low, and that adverse effects could not be documented; and providing an opportunity to test dose-response relationships extrapolated from higher doses. The conduct of some of these studies of exposed populations has been largely motivated by the need to offer reassurance to the public and to show evidence that an investigation has been undertaken. Land (36) and McMahon (37) have cautioned against studies of populations with doses only slightly higher than background, both arguing that an unfavorable signal-to-noise ratio assures uninformative and even misleading results. New approaches to sharpen the specificity of studies at low doses may obviate this justifiable concern.
The experience gained from these studies shows the limitations faced by observational studies at low doses. For example, Hatch et al. (38) investigated cancer near the Three Mile Island nuclear plant. Modeled dispersion of emissions was used to estimate population doses. The average increment-to-background dose was estimated to be about 0.1 mSV, about 10% of the annual dose. The upper limit was at about a doubling of annual dose. The findings showed no changes in cancer incidence indicative of an effect of the radiation releases from the plant, but confidence limits around risk measures were extremely wide because of the small numbers of cancer cases. Reassurance for the public can be found in the point estimates of risk, which show no consistent evidence of increase; the upper bounds of the CIs, however, extend well into a range of public health concern.
Unfortunately, accidental exposures continue. Each should be assessed for the need for surveillance and for more formal epidemiologic investigations. The exposed population needs to know the surveillance data. Unanticipated excesses of disease may then prompt follow-up investigation. For example, there has been a dramatic increase in childhood thyroid cancer in Belarus and the Ukraine following the Chernobyl accident (39) . This excess calls for investigation, including reconstruction of doses and estimation of dose-response relationships.
Conclusions
This review has emphasized research questions and methodologic advances related to the cancer risk associated with radiation exposure. It has emphasized key uncertainties related to the risks of radiation using observational data: dose response, dose-rate effects, and susceptibility. Advances have been made in the epidemiologic approach to quantifying the risk of radiation exposure, and mechanistic research promises to further reduce uncertainties. We should be able to address public concerns about radiation with increasing confidence, although the rising emphasis on the risks of lower levels of exposure has increased the challenge.
